Evidence map›Paper›PMID 24498454›Full record

ArticlePLoS neglected tropical diseases2014

Leptospira interrogans binds to cadherins.

Karen Evangelista, Ricardo Franco, Andrew Schwab, Jenifer Coburn

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Leucine-rich repeat proteins ofFrontiers in microbiology · 2024
    Article
  10. Review
  11. Article
  12. Editorial: Leptospirosis: pathogenesis, clinical and epidemiological aspects.Frontiers in cellular and infection microbiology · 2023
    Article
  13. Host Cell Binding Mediated byInternational journal of molecular sciences · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Heterologous production of the adhesin LIC13411 from pathogenicFrontiers in cellular and infection microbiology · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karen EvangelistaGraduate Program in Microbiology, Immunology, and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Ricardo FrancoDivision of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Andrew SchwabDivision of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Jenifer CoburnGraduate Program in Microbiology, Immunology, and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America ; Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
Medical College of Wisconsin · US

Funding

Cell-Binding Adhesins of Leptospira interrogansR21AI093509 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI COBURN, JENIFER L · 2012 to 2013
$421k
Adhesion of Leptospira interrogans to Human Cell Surface ReceptorsR56AI087835 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI COBURN, JENIFER L · 2010 to 2010
$383k
Adhesion of Leptospira interrogans to Human Cell Surface ReceptorsR21AI077560 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI COBURN, JENIFER L · 2008 to 2009
$379k
NIAID NIH HHS R21 AI077560NIAID NIH HHS R21 AI093509NIAID NIH HHS R56 AI087835
6 · The paper itself

Abstract

Leptospirosis, caused by pathogenic species of Leptospira, is the most widespread zoonosis and has emerged as a major public health problem worldwide. The adhesion of pathogenic Leptospira to host cells, and to extracellular matrix (ECM) components, is likely to be necessary for the ability of leptospires to penetrate, disseminate and persist in mammalian host tissues. Previous work demonstrated that pathogenic L. interrogans binds to host cells more efficiently than to ECM. Using two independent screening methods, mass spectrometry and protein arrays, members of the cadherin family were identified as potential L. interrogans receptors on mammalian host surfaces. We focused our investigation on vascular endothelial (VE)-cadherin, which is widely expressed on endothelia and is primarily responsible for endothelial cell-cell adhesion. Monolayers of EA.hy926 and HMEC-1 endothelial cells produce VE-cadherin, bind L. interrogans in vitro, and are disrupted upon incubation with the bacteria, which may reflect the endothelial damage seen in vivo. Dose-dependent and saturable binding of L. interrogans to the purified VE-cadherin receptor was demonstrated and pretreatment of purified receptor or endothelial cells with function-blocking antibody against VE-cadherin significantly inhibited bacterial attachment. The contribution of VE-cadherin to leptospiral adherence to host endothelial cell surfaces is biologically significant because VE-cadherin plays an important role in maintaining the barrier properties of the vasculature. Attachment of L. interrogans to the vasculature via VE-cadherin may result in vascular damage, facilitating the escape of the pathogen from the bloodstream into different tissues during disseminated infection, and may contribute to the hemorrhagic manifestations of leptospirosis. This work is first to describe a mammalian cell surface protein as a receptor for L. interrogans.

Indexed as

Bacterial AdhesionAntigens, CDCadherin 5CadherinsCell LineHumansLeptospira interrogansAntigens, CDCadherin 5Cadherins

Identifiers

PMID24498454
PMCPMC3907533
OpenAlexW1978308594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.